This expansion increases our global capacity to support drug handling for high-volume injectable therapies, including next-generation GLP-1 treatments
Common side effects include: Feeling sick (nausea) Vomiting Diarrhoea Constipation Indigestion or bloating These problems usually improve over time as your body becomes accustomed to the medicine
Otherwise, take the next dose at the scheduled time
Smart insulin and closed-loop systems On the insulin side, research is advancing toward glucose-responsive insulin formulations that would automatically adjust their activity based on blood sugar levels, essentially building in the safety feature that GLP-1 drugs inherently have
According to the company's website, sublingual semaglutide is available at $299 per month and sublingual tirzepatide at $349 per month based on platform-displayed pricing at the time of review
I would love to learn about how this happens and what it means for pharma, healthcare and future of care: Novo Nordisk launched Ozempic in India on Fridayand the weight-loss drug, which is also sold as a diabetes treatment in some countries, will sell at a massive discount there compared with U.S